Crossmark

Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen

Crossref DOI link: https://doi.org/10.1007/s00432-020-03206-w

Published Online: 2020-04-08

Published Print: 2020-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chan, Carmen W. H. https://orcid.org/0000-0003-0696-2369
Law, Bernard M. H. https://orcid.org/0000-0001-9571-6893
So, Winnie K. W. https://orcid.org/0000-0001-9243-2924
Chow, Ka Ming https://orcid.org/0000-0002-7442-5197
Waye, Mary M. Y. https://orcid.org/0000-0002-2582-4917
License Information

Text and Data Mining valid from 2020-04-08

Version of Record valid from 2020-04-08
More Information

Article History

Received: 24 March 2020

Accepted: 31 March 2020

First Online: 8 April 2020

Compliance with ethical standards

:

: The authors declare that no conflicts of interest exist.